No Data
JMP Securities Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $27
Exelixis Buy Rating Affirmed on Q2 Outperformance and Positive Litigation Outlook
With 73% Ownership of the Shares, Exelixis, Inc. (NASDAQ:EXEL) Is Heavily Dominated by Institutional Owners
Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Unusual Options Activity: KMB, BA and Others Attract Market Bets, KMB V/OI Ratio Reaches 183.3
Morgan Stanley Maintains Exelixis(EXEL.US) With Hold Rating, Raises Target Price to $26